Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment - Parodi, E; Nobili, B; Perrotta, S (Int J Hematol, 2006)
et al.